- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.08. | AirSculpt anticipates $12M-$14M adjusted EBITDA while rolling out AlloClae partnership | 2 | Seeking Alpha | ||
| 10.08. | Airsculpt Technologies, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 10.08. | AirSculpt Technologies Aktie bricht nach enttäuschenden Zahlen und Prognosesenkung ein | 1 | Investing.com Deutsch | ||
| 10.08. | AirSculpt Technologies Non-GAAP EPS of $0.01, revenue of $42.9M; reaffirms FY 2026 outlook | 1 | Seeking Alpha | ||
| AIRSCULPT TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 10.08. | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results | 558 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 10.08. | Airsculpt Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.05. | Airsculpt Technologies: BTIG bleibt bei "Neutral"-Einstufung | 3 | Investing.com Deutsch | ||
| 18.05. | Airsculpt Technologies stock rating held at Neutral by BTIG | 1 | Investing.com | ||
| 08.05. | Airsculpt Technologies, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 08.05. | AirSculpt outlines 2026 revenue of $151M-$157M while targeting sequential improvement in Q2 | 1 | Seeking Alpha | ||
| 08.05. | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports First Quarter Fiscal 2026 Results | 531 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 08.05. | Airsculpt Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 02.04. | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results | 299 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 17.11.25 | Airsculpt Technologies, Inc.: AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board | 426 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 07.11.25 | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Third Quarter Fiscal 2025 Results | 707 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,350 | +0,72 % | Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform | ||
| SERNOVA BIOTHERAPEUTICS | 0,063 | -5,09 % | Sernova Biotherapeutics Inc ÜBERRASCHT Anleger: Meine brandneue Prognose ändert einfach alles - Dringend vor Börsenschluss handeln! | ||
| CERENOME | 1,616 | +7,45 % | Cerenome, Inc.: Cerenome Launches CNSide CSF Molecular Profile Tests | HOUSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announced the commercial launch... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,160 | +0,93 % | Atossa Therapeutics schließt CVR-Vereinbarung für Erlöse aus FDA-Prüfgutschein | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-A12B/A, Registration of securities | ||
| TANDEM DIABETES | 14,800 | 0,00 % | Tandem Diabetes Care Q2 2026 Earnings Call Transcript | ||
| CO-DIAGNOSTICS | 1,250 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 12,000 | +1,14 % | Sanjeev Sharma wird neuer Leiter Investor Relations bei QuidelOrtho | ||
| VERU | 2,415 | +0,42 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| LIFEWARD | 6,360 | +1,92 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 4,370 | +2,10 % | Why Is Clover Health (CLOV) Stock Soaring Today | ||
| SENSEONICS | 8,300 | 0,00 % | Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript | ||
| TEMPEST THERAPEUTICS | 0,740 | -0,35 % | Tempest Therapeutics beruft Nancy Freda-Smith in den Verwaltungsrat | ||
| NANO-X IMAGING | 0,508 | -0,39 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen | |
| IMUNON | 0,950 | -0,52 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen |
Das Unternehmen AIRSCULPT TECHNOLOGIES INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,640 Euro und damit +0,61 % im Plus. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AIRSCULPT TECHNOLOGIES INC finden Sie auf Wallstreet Online.